RXE2
LIVE

Serial Number

88979456

Owner

RXE2 LLC

Attorney

Joshua G. Gigger

First Use Date

Apr 3, 2020

Filing Date

Jan 7, 2020

Add to watchlist:

No watchlists yet
View on USPTO

RXE2 Trademark

Serial Number: 88979456 • Registration: 6235550

RXE2 is a trademark filed by RXE2 LLC on January 7, 2020. The trademark is classified under Class 39 (Transportation & Storage), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

RXE2 LLC (7 trademarks)

FARGO, ND 58103

Entity Type: 16

RXE2 INC. (7 trademarks)

4302 13TH AVE. S., SUITE 4326
FARGO, ND 58103

Entity Type: 03

Trademark Details

Filing Date

January 7, 2020

Registration Date

December 29, 2020

First Use Anywhere

April 3, 2020

First Use in Commerce

April 3, 2020

Published for Opposition

June 2, 2020

Goods & Services

Pharmaceutical and medical device services, namely, providing pharmacist medical and scientific research counseling services to patients and healthcare providers as well as patients and healthcare providers participating in clinical trials for pharmaceutical, biotechnology, and medical device development and testing

Pharmaceutical and pharmacy services, namely, processing and dispensing online and telephone prescription orders for online clinical and retail pharmacies; maintaining a registry of national and international databases in the field of pharmaceuticals, medical devices, clinical trials, and healthcare; maintaining databases of pharmacies, pharmacists, and other healthcare professionals who can assist with the delivery of pharmaceutical services; promoting the exchange of information and resources within the pharmaceutical, medical device, clinical trial, and medical communities to achieve advances in the fields of clinical research and healthcare; providing a website featuring statistical data and feedback on healthcare provider's performance for the purpose of assisting prospective patients in making physician, pharmacist, and other healthcare professional selection decisions; recruitment advertisement services, namely, posting of clinical trial notices for the purposes of providing clinical trial status, and recruiting and informing patients for participation in clinical trials for the testing of drugs and medical devices

Pharmacy packaging services, namely, packaging, labeling, aligning and sorting medication by date and time into individual packages and containers for patients and healthcare professionals; delivery of goods for others, namely, delivery of medication, device and clinical supply packages and containers by date and time and category for patients and healthcare providers

Dispensing of medications by date and time and category for patients and healthcare providers; population health services, namely, gathering of global patient healthcare and behavioral data for the benefit of improving healthcare for individual patients, groups of patients, and populations; preparation of prescriptions in pharmacies; dispensing of pharmaceuticals; providing healthcare information; medical and pharmaceutical consultation; medical and pharmaceutical counseling via online or remote communication means; medical drug monitoring and alert service for healthcare providers and patients, namely, providing medication therapy management, medicinal dosage, allergic sensitivity, and prescription safety information for medical treatment purposes; telepharmacy services, namely, providing medical and pharmaceutical consultation and advice via online or remote communication means; providing information to patients in the field of administering, use and storage of medications; and providing medical information to patients in the form of reports in the field administering, use and storage of medications; and providing medical information to patients in the form of reports in the field of pharmaceuticals and medical devices

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 29, 2025 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 6, 2024 ASGN
REGISTERED-PRINCIPAL REGISTER
Dec 29, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 26, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 25, 2020 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Nov 3, 2020 SUPC
DIVISIONAL PROCESSING COMPLETE
Nov 3, 2020 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 26, 2020 AITU
USE AMENDMENT FILED
Oct 6, 2020 IUAF
DIVISIONAL REQUEST RECEIVED
Oct 6, 2020 DRRR
TEAS STATEMENT OF USE RECEIVED
Oct 6, 2020 EISU
TEAS REQUEST TO DIVIDE RECEIVED
Oct 6, 2020 ERTD
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 28, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 2, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jun 2, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 13, 2020 NONP
ASSIGNED TO LIE
Apr 28, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 22, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 1, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 31, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 31, 2020 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Mar 31, 2020 GPRN
PRIORITY ACTION E-MAILED
Mar 31, 2020 GPRA
PRIORITY ACTION WRITTEN
Mar 31, 2020 CPRA
ASSIGNED TO EXAMINER
Mar 26, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 10, 2020 NWOS
NEW APPLICATION ENTERED
Jan 10, 2020 NWAP